Mannkind Corp (MNKD)
$3.50 0.00% Close Oct 30, 2026 Live
Mannkind stock today
Mannkind closed at $3.50 on October 30, 2026, unchanged on the day. Over the past year it returned -36.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.08 billion.
$4.00$6.00
NovJan 2026MarMayJulSep
| Period | MNKD | S&P 500 (SPY) |
|---|---|---|
| 1 month | -10.3% | -0.9% |
| 3 months | -14.8% | +2.1% |
| Year to date | -38.3% | +11.7% |
| 1 year | -36.9% | +12.4% |
| 3 years | -15.9% | +88.5% |
| 5 years | -25.7% | +76.0% |
Key statistics
- Market value
- $1.08B
- Forward P/E
- 43.8
- Price / sales
- 2.8
- 52-week range
- $2.28 to $6.21
- Next report
- Nov 5, 2026
About Mannkind
Develops and commercializes diabetes and pulmonary disease therapies.
Sector: Health Care
More on Mannkind
- Financials: revenue, earnings and segmentsRevenue +22% in the year to Dec 2025
- Valuation: P/E history and peers
- Returns: what $1,000 became$1,000 ten years ago is $1,554 today
No forecast, no recommendation. This page describes Mannkind Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.